Sign up to save your podcasts
Or
Share Stock Market Crash or New All-Time Highs?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Stock Market Crash or New All-Time Highs?
BENZINGA HEALTHCARE SMALL CAP CONFERENCE
Wednesday, September 29 - Thursday, September 30 | Virtual
Register for our FREE Healthcare Small-Cap Conference and have a chance to win 1 year of Benzinga Pro! Register for FREE here
The Benzinga Small Cap Conference bridges the gap between Small Cap companies, investors, and traders. Learn about small cap investing with clearly defined Educational Modules, take a look at a curated group of Small Cap investment opportunities, and connect with the healthcare Small Cap audience in an intimate, virtual setting.
Episode Summary:- Whether to buy the dip in cryptos
- Whether to buy Vinco Ventures stock BBIG
- The Polestar SPAC deal GGPI
- Crypto Update
- Robert Kiyosaki Tweet
Stocks talked about on the show:
$NAKD, $BBIG, $CELH,$BABA, $GGPI, $SPY, $RGC, $NVDA, $TSLA
Join the Benzinga-Moomoo TRADING COMPETITION here
Get $50 in FREE Bitcoin when you use the code ZING on Voyager
Guests:
MyMD Pharmaceuticals Chief Scientific Officer, Dr. Adam Kaplin 21:00 (NASDAQ: MYMD)
Hosts:
Aaron Bry
Twitter: https://twitter.com/aaronbry5
Hot Stocks Luke Jacobi
Twitter: https://twitter.com/lukejacobi
Jason Raznick
Twitter: https://twitter.com/jasonraznick
- Subscribe to all Benzinga Podcasts here
- Get 20% off Benzinga PRO here
- Become a BENZINGA AFFILIATE and earn 30% on new subscriptions
Disclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.
Unedited Transcript
Everybody happy Monday. We are back at it another day, another week, another dollar to make I'm joined by Spencer Israel. But what is going on guys? This is the power hour. This is the trade idea show. We're spreading these 60 minutes together every single day, because we want to get the idea flow going, Spencer, how are you doing today, sir?
I'm well, well, I'm doing better than the Detroit lions are and that's all you can ask for. And I I'm in a good mood. It's Monday. It's a big week for us. I've been single. We get a lot of stuff. That I want to shameless, not sort of shamelessly plug, uh, here. Uh, but we'll get to all that. We'll get plug it, plug it now, and then let's get to repeat stuff.
Now we're only doing Rippy stocks today only to rip your stocks. All right. Yep. All right. Uh, oh man. So much to plug. Okay. Let's start with this tomorrow. All access event, um, myself and, um, me and I, uh, going to be talking alternative investments. We talk about stocks. We talk about crypto, um, but we don't talk enough about all the other assets you can have in your portfolio, whether it's real estate, whether it's venture capital.
Uh, we have a show tomorrow dedicated to alternative investments and, uh, how you can get exposure to the, the, not necessarily that you need. But that you should consider getting exposure to in some way, shape or form. So you don't just own, like, I have all your money in like the same five meme stocks or a BBG or whatever.
So that'd be tomorrow from 10 to noon. I'm excited for that. I also want to plug our next small cap conference, the small cap healthcare conference, which is in two days it's Wednesday and Thursday. You can go to B, Z small cap.com to learn more about that. There's the screen a screen is up on there. So BG, small cap.com two day conference tomorrow, Wednesday, Thursday, all day nine to five.
I'll be co-hosting that as well. What else did I want to plug? I wanted to plug. Oh, let's be snacks. Okay. Last thing I want to plug in and then rip the stocks stocks. Okay. Uh, for the very first time Benzinga has partnered with. We are, we are sponsoring a paper trading competition with mumo Moomoo. I'm going to put the, the, the, there is up on the screen.
Okay. So here's what you gotta do to, to play ball. You open a brokerage account.
You why don't I sound weird. You sound fine. To me, Spencer, you open a brokerage account through Moomoo. The link is in the description below. Okay. You fund your account with $500 and then you're eligible to participate. Well, why Albert to participate? What, what I win? Great question. First place winner in this contest gets 24 shares of Nvidia NBDA for free 24 free shares.
All right, hold on. I'm doing the math on that 24 times 2 15, 15. $215 and 15 cents IDs. Yeah. Okay. Second place gets 12 shares of Nvidia for free. So it's $2,500 about right. Third place gets four shares of Nvidia and fourth place. Everyone who finishes between fourth and a hundred gets one share of this other one, P D C O.
I don't know why they went random without one. They weren't Nvidia Nvidia, Nvidia PDCO, but everyone who finishes from fourth to a hundred gets PDCO one share of that for free. Um, so here's, what's going to do you click on the link in the description of this video, you open an account with Moomoo, you fund it with 500 bucks and then you two can play ball and Wayne, if you're the best paper trading winner, 24 shares of Nvidia for.
All right. And if you don't know what Moomoo is, I'll pull up this food to F U T you, you might know the ticker. Uh, this is actually a Jonah Lupton favorite. Um, but this is the holding company. It's like a, like a Robin hood of China type play in a Moomoo is their break into the U S I will be joining the trading competition.
So, and we, we only have links in the chat. Yeah. The link is in chat. It's in the description. We only have like a week or we have, let's see, it says you have to join by the 15th of October. So we have two, three weeks, three weeks to join. So there we go. So I wanted to plug that. I wanted to plug that's where it says right there.
I want to plug that. I want to plug our event. I want to plug our, uh, our all access event tomorrow, and now I'm done employing, and now we're going to rip the stocks. And I had a couple out of the chat Spencer. We're going to do Baba. Does it mean we have crypto? Yes, I believe so. Caleb, uh, okay. Uh, we're stocks.
Let's go first up on the list. Guys. If you have symbols, drop them in the chat we're diving straight in. We're going to try to five stocks, 15 minutes, three minutes, a piece, a naked brand cigarette, N a K D November alpha, kilo Delta. Uh, here is the look at the daily charts. Daily looks decent. We zoom it in to the minute charts.
First time of the day. We're starting to see a, a little bit of trouble over these past few minutes. Um, Spencer, any takes there? I have an opinion. Yeah. I have an embarrassing confession to make until about a minute ago because I've heard of naked brands before. And I've heard of like, I've obviously heard of the stock because it's a, it's a high flyer.
But until a minute ago, I honestly thought that this was the company that made naked juice and that's wrong. That is absolutely incorrect. That is wrong. But I. I thought this was naked. Thank you. Nope. Now that'd be a negative this entire time. This thing got to, you know, this thing went to three 50 or three 40 back in January go to their real websites.
Spencer, what? Naked brains.com. I don't know. Try it. Yeah, sure. Um, yeah, this is it. Okay. So for, for, for nine months I felt naked was like, it was the juice company that they make those really strong, fruity vegetable drinks. Now that'd be a negative. That was wrong. Okay. That shows you what I know anyway. Um, they can brands, this is their actual website, so let's go to the chart.
All right. So, so, so, so back to the chart, Spencer here, let me take it back over. Okay. All right. D here here's the daily candles. Okay. We're we're, we're, we're above this, this previous high that we had in there. Okay. We broke above that today. We, we got directed below. Ah, we got rejected. Below that on Friday, next previous high we're looking out for is all the way off at a bottle.
My I am long and strong naked right now. My opinion is that if, if we can buck this downturn that we've seen between when the show started and right now, uh, we're, we're in a decent position to keep running. This is definitely one of those docs that gets Mimi. It gets Rippy look at this, right. We saw that hop earlier this year from like 20 cents up to $3 and 50 cents.
Does it get there? I would, I would be skeptical, but if the momentum continues today, I think a dollar is absolutely insight, uh, from a pure technical basis. Yeah. A but a dollar is also like so pure technical energy to baby naked brand says energy power. You were just on the. I I'm, I'm just saying like a dollar is like, so psychologically significant that if like, okay.
I would just say if I wanted to, I don't even know if you can short the stock, but if you want shorter and you could, you, you wouldn't wait till a dollar, you would go, like, I I'm sure there's a lot of people at like 99 cents is all I'm saying. Sure. Yeah. Yeah. 95. I'll take it. Okay. 95, whatever. So, and strong.
I'm letting it rip today again, but between when this show started in now, what was the first sign of trouble that we've run into today? Right? These are the minute candles, uh, and we had a couple of decent size grad bars, but, but we'll see we're at 80 cents right now where we got to, uh, 80, almost 83 cents.
This, uh, that was the high of the day. So. There's one, five stocks, 15 minutes. Do you want me to call it or you want to pick next? All right. Next would be Sackler day. Ticker BBI, G Vinco ventures. Spencer. You talk to the CEO or chairman of the company. I don't remember which so the view. Okay. Remind us what the company does.
A Tik TOK. Uh, can I, it, it is take of India. Yeah, India and, and other geographies. Yeah. Right now we're looking at daily candles, obviously a ton of volatility over the past couple of weeks today, the stock is back in action. Up 16%, no news out on it. Um, I I'm, I'm curious. Where is everybody at with, with BB?
I G if you like the stock right now, drop the one in the chat. If not drop the. And, and even for, for let's, let's just play imagination. Okay. It's Monday, we got to wake up our fingers a little bit. If you're not taking a position one way or another one in the chat, if you would buy it here, two of you would sell it here.
I'm curious where everybody is at to having an opinion, too, for Spencer, I would sell it here. Um, I'm also a seller here, uh, and I'll back it up trend is your friend where we're in a downward trend for the past couple of weeks, uh, that the, the candle for today just moved rad, which means the stock is trading where below where it opened.
It's still obviously above where it closed on Friday, but we're now back below where it opened. Uh, we, we have the downward momentum. Uh, we have the red candle today. We have no news, uh, that, that came out to justify the pop that took place today. And so, um, I'm also going with the. Yeah, I would be against it.
If I had to pick one way or another important number on this is $8, right. That was the high that we got to add. So, uh, five 30 this morning, we are $8. So we're w we're we're, we're further off than it looks. If you only look, if you're ignoring the pre-market session, you're, you're missing the higher, the day $8 there.
So I would sell BBG here and I would, yeah, this is, this is not my style. This is your style. It's not my style. I love these types of styles. We're doing Rippy stocks today. All right. We did too. But I like BBG. I don't. All right. It could be wrong on him, but, but that's the way that I'm playing it today. And chat is pretty divided on this one.
We have just about as many ones as we do twos again, one was people like. Two was people don't. What about Celsius? All right. Let's, let's look at Celsius next. And then we're going to get to Baba in a second here, uh, Celsius. Uh, I'm also long and strong Celsius. If you don't know this one, it's like an alternative energy drink maker.
It's like, uh, uh, basically slightly healthier energy drinks, but I'm still, I'm sure. Still not great for you. Uh, you know, uh, all, all the fundamentals continue to be strong except for the valuation ratios on this one. And what I mean by that is that sales are still flying off the shelves. The company sells inventory problems because demand has been so.
The stock is very, very expensive. It's trading the teens of, of, of, of price, price to sales versus maybe like a four and a half times ratio on average for the S and P 500. Uh, that's sad. The sales growth, I think will keep the momentum alive. So I have been long and strong, uh, Celsius from the seventies.
Wow. We're at, I know it's a good grade. So do you have a plan here or are you just riding the wave? I'm riding the wave baby. If momentum cracks that, then we'll hop on. Um, what does that mean? If momentum cracks, if we get so, so today we're off 5%. That's a painful day. It's the biggest loser in my portfolio was a position.
It was, it was, it was a big position that one of the largest positions that I put on it grew to be larger. We're off 5% today. The, the portfolio is, is definitely bleeding from that one still green today. Thank goodness. But this is, this is the biggest, the biggest hit to the portfolio of the day. Uh, if we get another ride candle like this tomorrow, uh that's when I'll start rotating out of it.
Yep. So all it'll take is, is like another, another 5% day. Yeah, yeah, yeah. We have a 1% day. Okay. Maybe the tide is turning, but if it's another day of, of rad and we're down off another 5% Obama out of it. Wow. Okay. Short pay, uh, short trigger finger. I like it. Cause, cause you've got. Yeah, exactly right. It's been several weeks.
We wrote it from 70 to 95 right now. Great freaking trait. Thank you, sir. Yeah. So now he's going to wait, you know, right in 94. So let's say if Luke wakes up tomorrow and saw ceases at 90, he's done. And, and, and here's what I'll say too. Obviously we can't predict too far into the future, but this is a stock that I will absolutely look at to trade into earnings again.
So it's the next earnings date is scheduled for 11, 11. Make-A-Wish Spencer. Whoa. And here's the, but it's one that, again, I'm not, I'm not saying that I would, would hit it long back into earnings, but it's one that I will absolutely look out long back into earnings. Because again, that the story is, is, is the fundamental one.
The stock has the momentum right now, um, which I check out the sales growth on this. And Spencer's, this is quarterly revenue. Uh, over the past year, we went from $30 million of sales to $65 million. What is the market cap here? I said that all the fundamentals are great, except for the ratios. Okay. For a company that made 60 million mill million with an M quarter of quarter.
All right. Here's my question. Is are they going to, going to come out and blame a supply chain of woes? Yeah, but they already have. Oh, they did. Okay. Revenue will still be good. They'll still blame supply chain and they'll they'll they'll beat and raise again. That's all I do. They're just beaten. Or he's beaten, raised, beaten race.
Fine quarter after quarter after quarter. Oh man. I know. Look I, who am I to poopoo this you've written the wave. Great trade. The new Navy. I just ride wave valuation means nothing. When you're up in your position, when you're down, it means everything. But when you're up, it means nothing. So it's a great track.
Good. Great job, man. Good job. Alright. Five stocks, 15 minutes next up on the shot pocket. Yeah, this is Alibaba's thing is, is, um, I can understand why you would look at this. Why anyone would look at this and say, oh, how could I not take a flyer? Right. It got to 1 44 this morning. I can understand the temptation for a stock that was basically $300 a year ago.
It was 300 pockets. It's coming to zoom. Yeah, Spencer. So, so now we're looking at a five-year chart with, I believe monthly candles. Yes. These are monthly candles. I now brutal. It's brutal. It's brutal. Um, if you want to take a flyer, I guess I would say if you do whatever you want, but waiting the flyer on this one is with long dated calls.
In my opinion, we, we, we, we looked at them briefly last week. I didn't take any action on it, but, but, but basically I think it was though one 70 calls that were about a year and three months out, 15 months out or something like 13 bucks. So, so it's definitely on my, keep an eye on it list. I think if you want to take a flyer, it's a pretty capital efficient way to do it.
That's PR yes. That's probably the most efficient way to do it is, is, is leaps. Um, cause you know, you have it, you have it defined a risk and, and it's efficient use of capital and you're you, and you're not married to the next few months or because this thing could, oh, who knows where it's going to stop, but.
I don't know, like part of me wants to, and part of me doesn't, I'm hands off for now, but it, gosh, does it walk? Does it look like a snack as Neil would say, right. I 1 48 here do it Spence. I I'm not going to do it, but there was a part of me that absolutely wants to do it, wants to buy this stock or, or I'll buy some long data calls or whatever, thinking about it in the chat.
Uh, he sold Baba puts for one 20 expiring this Friday. Wow. Yeah, I think it's a decent trade. It can't be a highly lucrative trade. So basically as long as Bob was at one 20 or above by Friday. So it's 1 21. No, not one 20. Cause it's it's whatever he, he pocketed from, from the sale. Right. So let's say it's a dollar.
It's not going to be much. No. All right. You're right. You're right. Um, all right. If anybody else has any action on Baba, put your trade in the chat long, short. I want to see where that's at. Yeah, it does. Look, I look, you guys know, I own all these Chinese internet stocks for, for years. And then I sold via the one ETF and I sold that and I'm out and Spencer five stocks, 15 minutes more on the list.
One more. And then we're going to have to bring on our guest, our first guest, the one on Europe on your list. G G all right. We have a new spec deal guys. News one year chart, daily candles. This was a pre announced back and has now announced a deal. Uh, I know that we're coming off of SPACs attack. Uh, but, but this one, we, we have a little bit of a.
Experienced with a company called Pollstar, which is Volvo's, uh, electric vehicles. Company has been funding. You, you test drove this car, did you not? I drove the shit out of this car. I would say Spencer. Th that's the technical term. That's the technical term. Yes, we, we got one of these vehicles at Benzinga, uh, again for fully electric car it's it's the company that, that Volvo has been funding, uh, and it was a pretty awesome ride.
Uh, you know, the styling, I didn't think was like very impressive or interesting. Like we see out of a lot of these new Evie companies, uh, but the drive was incredibly smooth. The car was incredibly fast and the interior was, was great, uh, amazingly comfortable. Um, so, so I was a, a big fan of the drive experience on the book.
Okay. I, I mean, I w I wouldn't know, I wasn't invited, but it looks amazing. I will say that it looks nice. And in this, the thing was fast, Spencer, I didn't even have the fast version. All these electric cars are so fast. Th the only thing, like, you know, what's wild here is like, okay, in Eve you spec the old th that's.
So in an EVs back in September, that is so 20, 20. That's like, you know what I mean? Not so lucid of them, these guys are like a year late, aren't they? No, yes. So, so here, here's my, here's my take on the trade. Uh, if I had to pick one way or another, uh, and, and, and I may get into this one later today, I would pick it long.
Uh, again, I think it's, it's one of those names that the vehicle is, is interesting to look at. It's headline. Um, they, they are starting to get out onto the roads, at least in a test capacity. Um, so it's a little bit further along than lucid as I believe. Uh, but if I had to pick this one for a swing trade one way or another, I would definitely think along.
Wow. All right. I was surprised to see this today. I didn't, I thought we were done with the EVs facts, but I, yeah, I thought we were done with the, I guess we're not. All right. Look, we're running a little bit late here. Uh, we got to bring on our first gas. All right. All right. Let's do a Spence. All right, Dr.
Adam Caplin, who has forgotten more about science than you and I were even know he's a PhD. He's also the chief scientific officer of my M D pharmaceuticals. Here we go. Dr. Caplin. Good morning, sir. Oh, no, you're on mute. Check that mute button on the bottom there. Thank you. Technical things that are difficult.
Always the technical things that are tricky and. I'm doing well. And how are you, Spencer? It's a beautiful day. We finally have our fall a days here in Baltimore, so we're enjoying ourselves. Nice, nice. I have a soft spot for Baltimore. I went to the university of Maryland and so I have a soft spot for Baltimore and, and, and that state, uh, Adam, let's talk about my MD for a second.
Thank you to ever put the, uh, the ticker up on the screen there. Uh, that wasn't me, uh, for those who don't know, tell us what, uh, my MBA, what you're working on. Well, we're working on two main, um, uh, drugs under development. One is my MD one and the other is superior CBD. My MD one is looking to be, um, a game changer in the area of treating auto-immune diseases and delaying aging and superior CBD is as the name implies a super new form of CBD.
Explain that a super new form of, yeah. So essentially it's not a huge change to the molecule. Um, it takes one of the six member rings and turns it into a five member ring. Um, more details than you would possibly want to know, but essentially the Tran, uh, the, the outcome of that is that not only, um, so first of all, you have to understand there's two binding sites that we all have within our bodies and our brains and the immune system for any cannabinoid, meaning THC, any marijuana based drug, um, one is CBD one, the other is CBD.
Sydney one is what gives you the intoxication? The high from THC and marijuana CBD too, though, is a really unique receptor. That is the brake of the immune system and has very potent anti-inflammatory effects and the ability to help preserve neurons, um, and preserve, uh, you know, the brain other under attack.
So what's really unique is we first found that superior CBD bound four times more tightly to the CB two receptor, but binding isn't the isn't the key. The key is once then, what does it do? And it turns out that superior CBD when it's bound to that CB two receptor, the one that's on all the immune cells and in the brain under, uh, under attack, either epilepsy in the light.
Is, um, 8,000 times more potent at activating the CB two receptor. So that's a huge difference. It really is a very potent drug at activating the OD the break for the immune system and preserving neuron, neuronal function of the brain. What exactly is going on here? You have, you have, uh, studies, uh, you have two drugs in the pipeline.
You have studies going. What is the status of those? Where are you in the regulatory? Yeah. So that's a great question. With superior CBD, we are doing the preclinical studies. It's the newer kid on the block for us. And, um, we are currently undergoing all of the, uh, regulatory toxicology studies and safety studies were about a year from being able to get that into humans.
Um, my one has already completed its phase one studies. And this year we plan to start two studies, one looking at aging and the other, looking at COVID-19 to treat inflammation and, and to slow aging down. All right. So we're still early days in this. Process for the superior CBD, where early days for my MD, when we're getting into phase two sorority, looking at treatments for aging, and COVID-19 in humans this year, we're going to start to two of those studies.
So we're much further along it's, it's, uh, a molecule that we've been working on a much longer. How long have you been working on it? Um, it has been roughly four years. I should tell you, I joined the company a year ago. So, um, you know, I most familiar with the stuff that's happened since then, but, but it has been, uh, working on, we've been working on it for four years.
So we have the safety, uh, the toxicology studies and all of those. Uh, and do you have, I guess you're, you're getting into phase two right now. Uh, do you have an idea of when, of when that could start even, even end the, the. Yeah. So there's two trials. One is that COVID-19, um, you know, it's obviously still going on, which really dramatic about COVID 19 is that it's the inflammation that causes all the trouble.
And so my NB one is, has both good effects on blocking inflammation and bringing it down and slowing aging. I'm happy to talk about a very exciting study that's under review right now, um, out of a major academic institution, but, um, so the first thing, the COVID 19, it turns out that that inflammation has effects on the brain, including brain fog and depression, post COVID.
These are very common up to 50% of people will have, um, a post COVID depression due to the inflammation and this brain fog that often goes along with it. So we are studying the ability of my to treat that, and that will be a second. Uh, treatment trial. So because it's only six weeks, we should be able to get everybody enrolled, um, this year and have the results in the first quarter of next year.
The second study is on aging and that study will be a six month trial. So we started this year. Um, it's going to be probably a fourth quarter of next year that we'll have the results. Alright, so I have, uh, two, two trial results, one in the first quarter, one probably around a year from now. Yeah, that's that's I think that's a reasonable assessment.
Can I tell you about the, the aging, uh, the result out of this, a major academic institution what's really remarkable is that currently the best treatment that has been seen in animals to extend the lifespan of animals in terms of a drug is rapid myosin. So this study using my MD was comparing my MB to rapid myosin and rapid myosin plus Metformin, but that.
Complicate things and what happened, but you have to understand finding a drug that can actually delay aging is so critical. So this study took mice that were the human equivalent of 60 years old and treated them until they were the human equivalent of 90. And essentially being on meant that you were four times, 400% less likely to die.
If you're on the, my MD than if you were on the rapid myosin. And that's a huge impact, highly statistically significant. And we think we're working towards an understanding of how this actually works. The critical thing, Spencer though, is it didn't just extend the lifespan. It, these mice retain their. And their cognition.
So it's not just a drug that could, if it works in humans, like it works in mice, uh, extend the human lifespan. It could slow aging. So it's not like we're all just going to get old and demented, we're all going to lead longer, more productive lives. If it doesn't humans would it doesn't matter. All right.
Well, we'll know more regardless. Uh, next year, Adam Kaplan is the chief scientific officer of my MD to grim YMD, we'll know more from the one trial and in Q1 and then the, the, the longer trial, uh, in, in, in Q4, hopefully next year, Adam, thanks for coming today. Thank you so much, but if you're always a pleasure to work with you and right.
I see a bee producer. AB is he here? I just saw him. I just saw him producer. AVRC you lurking. I see you lurking. Uh, while he's getting his stuff together, let's just do a real quick. Crypto update because, uh, I oh, there is. I heard my name. Yeah. Hey, how's it going? Tell the people why you leave today. Um, so I was just at a press conference at, uh, the Detroit golf club for the rocket mortgage classic.
Uh, they were announcing that rocket mortgage is extending their sponsorship of the tournament, um, through 2027. So some exciting news, just have one question. Will Phil Mickelson be at the next one? I don't think so. Based on last time he, uh, some Detroit writer did not make him happy. Yes. Yes. Anyway, wait, I just want to do a quick, quick crypto update then we'll go to our next, get our next guys.
Cause that same here real fast. AB why did you bother different crypt? They want a Friday, cause I did not. I kind of a. Uh, I just didn't. I know, but, uh, Spencer, so I'm in a couple fantasy football leagues where we're talking about, well, really just one. We were talking about like putting our pool for the league into crypto and we were texting this weekend, like, oh, now would be a good time to throw it, you know, in a theater.
We want, we want to throw it in something that really has a chance to like double in the next six months.
Okay. Hey, however you figure that out. You let me know. Okay. Got it. Yeah. I'll let you know how it goes. Uh, whether it's Towanna, uh, eith I dunno, BTC. Those are the three that I on Cardona. I dunno. Um, but here let's you go to a charter for a second and then we'll, and then we'll go to our guests. Yeah. So, so we had that sell off on Friday and it happened, like, you can see there that we actually closed, you know, about halfway between, uh, the high and low of the day in Bitcoin.
And so, uh, we kind of came back so fast. It, I kind of feel like I missed my chance, so I didn't, I didn't do anything basically. In summary, I did nothing on Friday. I thought about it. I talked about it and I did nothing. It's the same thing, right? Charts are identical thought about it. Did nothing. I want to know if anyone bought more.
I should have, I, I, I always regret not buying more. Every time I regret not, I think on, on some different brokerages now you can set recurring buys. So like, I don't think it would be dumb to set. I should've just dollar cost average. I don't know how, I don't know how to set it up though. Maybe I, I, what brokerage are you using?
Yeah, I'm using Coinbase. Is that, is that bad? I don't know. I mean, I'm sure on Coinbase, I know Robin hood, they just like enabled recurrent investments into crypto. So I'd imagine Coinbase. So you can too, um, since obviously Coinbase is more crypto focused than the only reason I use Coinbase is cause I literally just like did eeny meeny, miny, Moe.
I was a guy one like, yeah. There's no special reason why, why I use it. It was, it was a spontaneous thing. I didn't think about it. I didn't do any research. I didn't think about it at all. I just did it. Um, anyway, speaking of crypto and buying it, you can get $50 in Bitcoin for free. All you gotta do is download the Voyager act.
Fund your account with a hundred dollars, make your first trade and use the offer code zing that Z I N G it's up on the screen that will get you $50 in Bitcoin for free. The crypto updates that we do are brought to you by Voyager. I should, maybe I should just, I should probably switch off Coinbase. I, I have no allegiance to them at all.
Even if you go to Voyager. Yeah. I don't know. I don't know because I swear, I don't know how to use that app at all. Anyway. Uh, okay.AB it's 1247 and we didn't get to any of your stocks that I don't know what you, what you have on your, yeah, I've got a couple of things, Spencer. So first of all, um, you know, if you notice the title of this video stock market crash or new all time, and you're wondering, uh, you know, what's sad about, so over the weekend, um, the real Kiyosaki, I hope I'm saying that, right?
I saw this tweet tweet on Twitter. He made a big waves in the fin twit community. This is the author of rich dad, poor dad, which is a very popular book among investors. Um, full disclosure. I have not read it. Let me know in the chat, if you think like, oh, B you must read this book. Or if you're like, oh, you've, you've made it this far without reading it.
You don't need to. Um, you know, so anyway, he, he tweeted giant stock market crash. Come in October. Why treasury and fed short of T-bills gold, silver Bitcoin may crash to cash best for picking up bargains after crash, not selling gold, silver Bitcoin yet have lots of cash for life after stock market crash stocks, dangerous.
Careful. So this caught a lot of headwind among the investors. Um, you know, uh, this guy Kiyosaki, he's known for kind of making some hot takes on Twitter regarding Bitcoin. Yeah. I never met him. I don't know him. I've also never read his book, but I will say this. He has made these calls before. This is not the first time that he has come out and well, I'm glad you mentioned that Spencer.
Cause I was just going to bring up this in the replies and someone essentially like super imposed some of his tweets over the S and P 500. So dating back to 2011, um, you know, he's been calling for a crash like periodically, uh, I'm an actor and actually here, let me try to zoom in a little bit. So you guys can see Spencer.
I don't know if you can make this full screen. So here, um, this one in 2018, he's he retweeted an article, I guess essentially saying that a biggest crash has come in and to his credit, there was a strong dip, uh, kind of like directly after that, but nothing really of a crash. And the only time he was ever somewhat vindicated was here in the COVID crash, which of course, uh, you know, an obvious factors playing into it.
Other than just, he said the crash is beginning on April 17th. It was already over by. Oh, no. Yeah. He's yeah. Crash only beginning, April 17th and the, and the markets from then, you know, went way higher than the previous levels before the COVID. So, you know, to say he's been wrong numerous times and calling this out would be kind of an understatement.
Someone else on Twitter, you know, said, if you listen to him, your returns would be 0% since 2012, because, uh, I guess 2012 was the first time he recommended kind of going all cash. Um, so I don't know. So it's, I mean, it's one of those things to me, that guys like this, that, that keep calling for a crash eventually they'll say, Hey look, I was right.
But it's like, yeah, but you were wrong for 10 plus years and you missed out on all these gains, you know, from the spy. Yeah. Christian gala Gallagher, and the Chad saying he will be right eventually. I mean, yeah. If I keep saying, Hey, the, you know, the market's going to be down every day. Eventually I'll be right.
I, if you call for the world to end one day, the world's going to end. You're going to be right. It's just a question of, are you alive? Yeah, right. Um, so, so I, you, so the title of this video, again, I made it stock market or new all time, high stock market crash, or new all time highs. Spencer, we've talked about this before.
You and I are both on the side that we will see new all-time highs before the end of the year. That's not saying we're, you know, Betty don't, you know, whatever. We're just, if we had to pick, will there be new all time highs or will there not be we're on the side that we think there will be? So, yeah, I have a bet on with joy and the bet is referring to the S and P 500 specifically, which I actually don't know how great I feel about that because the more I look at the spa or the S and P 500, the more I realize, not that I haven't known this, we've all known this obviously, but the spy really is just, it's just six stocks, right?
It's it's it's fat man. Right? F a T M a N. Right? It's Facebook, apple, Tesla, Microsoft. Alphabet, Amazon Netflix, right? Those right. I got there, right. Fat man. Yeah. Fat, M a N uh, seven, seven stocks. And whatever those seven stocks do is going to be whatever the S and P does. Uh, w w let's just do a quick, let's just do a quick, um, let me go here we go.
Want me go to ETF, db.com and we can, excuse me, let's do some quick math in our heads. All right. No, not in our heads. Yeah. In our heads. Okay. Uh, let's let's add up these, these holdings. So apple is six plus six. We'll call it 12. Uh, we'll call that 16. Uh, we'll call that 18. We'll call that 20, uh, oh, wait.
It's actually, um, Yeah, it's alphabet for cause there's two share classes, but, uh, uh, so call it 22, call Tesla. We'll just call it 20. You want to call it 25? Ian we'll call it twenty-five even actually the end in fact, man could be Nvidia. We'll call it 20 or so. So 1, 2, 3, 4, 5, 6 stocks are 25% of the S and P give or take.
Um, it's not exactly, obviously. Um, and so it's, whatever those six are going to do is whatever the spine is going to do, basically. Right? So a day like today, where like you could say the market is up Mo there was way more green than there is right today. And yet the spies on the red, because those six stocks are not.
But if you look at the IWM. I have a great day. Wow. I'm looking at Tesla right now up about two and a half percent, almost at $800. I feel like Tesla has quietly, um, you know, gotten back up to $800, maybe a little bit absent with some of the attention that Tesla has gotten in its previous runs, maybe, cause it's just been kind of a steady climb to 800 over the past, uh, you know, four months or so, as opposed to it being up 10% every day or whatever.
But, uh, I mean the chart looks insanely good right now. Congratulations. Hertz comes and says that was as best day all year. That's great. Um, so anyway, to bring it full circle, I do have a bet on that thing that says, we'll get the essence, a new all-time high in the S and P by the end of the year. Um, but it's really what it comes down to is whatever those six docs do is what it's, what the SOP is going to do.
So I, I'm going to try and wean myself off of the S and P um, it's hard though, to just use it as your gauge, but. I'm still balling. You're saying you don't think it's a effective gauge because it's so heavily weighted among those. Yeah. I mean, we talked about, we've been talking about this for months. I'm pre-market prep, but it's hard to change to change your behavior.
And I did recently, not recently, like a year ago, I think I changed the weightings in my, this is like super, like, I don't know, not narrative, you're not wonky, but this is just like, this is super boring, but I changed the weightings in my 401k to be 75. I have two funds, a small cap and a large cap, and I made it to be 75% small cap, 25% of large cap.
Wow. Yeah. Um, what was the thought process going into that? Originally? It was flipped and then I, I realized, no, I want to play with the other way. Small caps is a historically outperformed and well large caps. It's this it's really not, it's not even large cap. Six mega caps. And I was like, I don't want these six docs.
So essentially, I mean, obviously, you know, you said small caps, like historically tend to over-perform, but I think over the last, like 10, 15 years though, you know, the apples, the Google Facebook have just had ridiculous returns compared to the small cap. So you're saying essentially you're betting on that.
There'll be a, kind of like a reversion to the means and the small caps got to catch up with these big guys eventually. Yeah. I mean, there, there is data. Hold on a sec. I'm trying to find the page where I, uh, where I, I favorite thing, I kind of agree because it's like, look from 2000 to now 2021 for the past 21 years, the best investments have been, you know, Amazon, apple, Google.
And I think it's like time now that we start looking. Forward to the next, um, you know, what will be the next, the best investments of the next 20 years? Maybe it, maybe it is still apple, Google, whatever, but I think we might, you know, get some new, um, see, I just don't know. What's what are the most innovative companies out there right now, um, that are going to be more that are going to be able to grow at the pace that apple, Google?
I don't know. So when I say historically small caps outperform, I'm not referring to the last decade. The last decade, large, you guys know this large caps, dominate, dominate, dominate, dominate annual, um, gain of call we'll we'll call it temporary. We just round up, but call it 10%, right? Just 9.8% annualized gains, huge small caps around 8.9%.
Uh, but if you go back like 20, 30, 40, 50 years, small caps have the edge, if you go back further. So I, I don't know the answer to your question AB um, But maybe, maybe it's the group of stocks that's been like that we're like rallying, like crazy. And I've been beaten down this year. Saw someone mentioned DocuSign.
DocuSign is actually held up, rotate that stock's just so expensive. I feel like, I don't know. That's the problem is he, these stocks like, like you, you might love a zoom or DocuSign or a, I don't know, a Roku or a square, but they're just, I think let's think about it this way. So the companies, the mega caps that have grown over the past 20 years so much, you know, whether we're talking apple, Microsoft, Google, um, they're they were kind of in emerging markets in a way.
So you think about it like apple, like smartphones. When smartphones became popularized, apple was in a position to put out the iPhone and become the most popular smartphone smartphone. So I think if we look at like, what markets do we expect to continue to grow? So, you know, we've seen it with EVs where like a lot of these companies, like you said, just got super expensive and then now are, are getting beaten down.
I think there will be kind of winners and losers out of those. Like, I don't think every single Evie stock that ran back and who's going to pick the winner. Not me, not me. Probably Warren, probably, maybe no. Warren, you think Warren Buffett's in a bind and Eve stocker you're out of your mind? Not now. Well, Spencer.
He, one of his biggest holdings is in a BYD, which is an Evie company. Second of all, I think once he is able to identify like the companies that make money, these Evie companies don't make money. Well, like I said, he's a big investor in this BYD Evie company, so he's got to believe in it somewhat. Um, yeah.
Thank you, Chris. Backing me up in the chat. Uh, I think he'll, he'll recognize be able to recognize which one of these companies will be able to make a bunch of money. Um, other emerging markets that I could see coming in the next 20 years, I think there's a lot of, um, things in the medical field that will be big, whether that's tele-health, whether that's, uh, and I'm not just talking like biotech companies that make different drugs.
I I'm saying like companies that will kind of like revolutionize health. Uh, so I've already made these calls in my portfolio. I've already made these calls. Okay. Here are your big ones. This is my portfolio. Okay. Let me make the names bigger so you all can see, okay. I've already made these sector. I like making sector wide calls.
Okay. I've got cannabis. I've got cyberspace. I've got 5g. I've got e-sports. I have a very, very, very small piece of space. I literally have got like, probably like 10 chairs of space of, of UFO. Right. Very small. Okay. I've got a biotech. I've got this, uh, the, um, uh, SRV, R it's it's a, it's a data center REIT.
It's basically just like, it's a read that owns data centers and server centers. Okay. Love it. Everyone needs data. Now, whether you're in the sports gambling industry, whether you're in healthcare, everyone needs, everyone needs. Yep. I've got blog. I've got the blockchain ETF, a little bit of that. I've got clean energy PBD.
I've got small cap industrials and the, and these are the calls that I'm making. And for a lot of the year, it's been pretty brutal to be in e-sports. For example, it's been horrible, but I don't care about this year in e-sports. So I've made my calls, cannabis, cybersecurity, e-sports 5g biotech server. Ah, small cap industrials and clean energy.
That's what I've got a Christian there's two BYD is there's Boyd gaming. Um, which is what I think you're referring to. There's also someone through the ticker in the chat it's on the OTC, since it's based out of China, it's like BYU DDF, I believe. Um, it is a Chinese Evy battery maker, or maybe they make cars too.
I don't know either way Burke share, uh, and Warren buffet holds a significant stake in there. So, um, might be wanting to check out, but Spencer, we are wrapping out of time. I'm going to see if Neil is ready. Um, oh yeah, shout out and Verso win a year of Benzinga pro entered one a year. Benzinga pro if you sign up for our healthcare conference, that is starting on Wednesday.
Um, if you go to BZ, small cap.com, you can sign up for free and, uh, yeah. Enter to win a free year. Benzinga pro yeah. I have a last thing to plug again. Just as a reminder, check out the Benzinga Moomoo trading competition. AB probably has no idea what this is, but that's okay. He's not paying attention. Uh, so click on the link in the description.
First place gets 24 shares of Nvidia for a free second place gets 12. Yeah, it's, that's a lot of money. Five grand, man. Am I allowed to participate yet? It's yes. Click on the link in the description. I already have some shares of Nvidia, but for opening an account or Moomoo funding with the $500 and you are eligible to, to participate in the Moomoo and Benzinga us paper trading competition.
Uh, the last day to enter is October 15th and it ends on the 29th. So the link is in description. It's also in the chat and don't say, didn't warn you because I do. I warned you. There we go. All right. That's a wrap for power hour today. Let's get Neil going on, get technical, everyone smash that like button and, uh, we'll see.
Y'all later. It's the green today. Everyone. It's a green, it's a green day.
Support this podcast at — https://redcircle.com/zingernation-power-hour/exclusive-content
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
View all episodes
By Benzinga
3.9
77 ratings
BENZINGA HEALTHCARE SMALL CAP CONFERENCE
Wednesday, September 29 - Thursday, September 30 | Virtual
Register for our FREE Healthcare Small-Cap Conference and have a chance to win 1 year of Benzinga Pro! Register for FREE here
The Benzinga Small Cap Conference bridges the gap between Small Cap companies, investors, and traders. Learn about small cap investing with clearly defined Educational Modules, take a look at a curated group of Small Cap investment opportunities, and connect with the healthcare Small Cap audience in an intimate, virtual setting.
Episode Summary:- Whether to buy the dip in cryptos
- Whether to buy Vinco Ventures stock BBIG
- The Polestar SPAC deal GGPI
- Crypto Update
- Robert Kiyosaki Tweet
Stocks talked about on the show:
$NAKD, $BBIG, $CELH,$BABA, $GGPI, $SPY, $RGC, $NVDA, $TSLA
Join the Benzinga-Moomoo TRADING COMPETITION here
Get $50 in FREE Bitcoin when you use the code ZING on Voyager
Guests:
MyMD Pharmaceuticals Chief Scientific Officer, Dr. Adam Kaplin 21:00 (NASDAQ: MYMD)
Hosts:
Aaron Bry
Twitter: https://twitter.com/aaronbry5
Hot Stocks Luke Jacobi
Twitter: https://twitter.com/lukejacobi
Jason Raznick
Twitter: https://twitter.com/jasonraznick
- Subscribe to all Benzinga Podcasts here
- Get 20% off Benzinga PRO here
- Become a BENZINGA AFFILIATE and earn 30% on new subscriptions
Disclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.
Unedited Transcript
Everybody happy Monday. We are back at it another day, another week, another dollar to make I'm joined by Spencer Israel. But what is going on guys? This is the power hour. This is the trade idea show. We're spreading these 60 minutes together every single day, because we want to get the idea flow going, Spencer, how are you doing today, sir?
I'm well, well, I'm doing better than the Detroit lions are and that's all you can ask for. And I I'm in a good mood. It's Monday. It's a big week for us. I've been single. We get a lot of stuff. That I want to shameless, not sort of shamelessly plug, uh, here. Uh, but we'll get to all that. We'll get plug it, plug it now, and then let's get to repeat stuff.
Now we're only doing Rippy stocks today only to rip your stocks. All right. Yep. All right. Uh, oh man. So much to plug. Okay. Let's start with this tomorrow. All access event, um, myself and, um, me and I, uh, going to be talking alternative investments. We talk about stocks. We talk about crypto, um, but we don't talk enough about all the other assets you can have in your portfolio, whether it's real estate, whether it's venture capital.
Uh, we have a show tomorrow dedicated to alternative investments and, uh, how you can get exposure to the, the, not necessarily that you need. But that you should consider getting exposure to in some way, shape or form. So you don't just own, like, I have all your money in like the same five meme stocks or a BBG or whatever.
So that'd be tomorrow from 10 to noon. I'm excited for that. I also want to plug our next small cap conference, the small cap healthcare conference, which is in two days it's Wednesday and Thursday. You can go to B, Z small cap.com to learn more about that. There's the screen a screen is up on there. So BG, small cap.com two day conference tomorrow, Wednesday, Thursday, all day nine to five.
I'll be co-hosting that as well. What else did I want to plug? I wanted to plug. Oh, let's be snacks. Okay. Last thing I want to plug in and then rip the stocks stocks. Okay. Uh, for the very first time Benzinga has partnered with. We are, we are sponsoring a paper trading competition with mumo Moomoo. I'm going to put the, the, the, there is up on the screen.
Okay. So here's what you gotta do to, to play ball. You open a brokerage account.
You why don't I sound weird. You sound fine. To me, Spencer, you open a brokerage account through Moomoo. The link is in the description below. Okay. You fund your account with $500 and then you're eligible to participate. Well, why Albert to participate? What, what I win? Great question. First place winner in this contest gets 24 shares of Nvidia NBDA for free 24 free shares.
All right, hold on. I'm doing the math on that 24 times 2 15, 15. $215 and 15 cents IDs. Yeah. Okay. Second place gets 12 shares of Nvidia for free. So it's $2,500 about right. Third place gets four shares of Nvidia and fourth place. Everyone who finishes between fourth and a hundred gets one share of this other one, P D C O.
I don't know why they went random without one. They weren't Nvidia Nvidia, Nvidia PDCO, but everyone who finishes from fourth to a hundred gets PDCO one share of that for free. Um, so here's, what's going to do you click on the link in the description of this video, you open an account with Moomoo, you fund it with 500 bucks and then you two can play ball and Wayne, if you're the best paper trading winner, 24 shares of Nvidia for.
All right. And if you don't know what Moomoo is, I'll pull up this food to F U T you, you might know the ticker. Uh, this is actually a Jonah Lupton favorite. Um, but this is the holding company. It's like a, like a Robin hood of China type play in a Moomoo is their break into the U S I will be joining the trading competition.
So, and we, we only have links in the chat. Yeah. The link is in chat. It's in the description. We only have like a week or we have, let's see, it says you have to join by the 15th of October. So we have two, three weeks, three weeks to join. So there we go. So I wanted to plug that. I wanted to plug that's where it says right there.
I want to plug that. I want to plug our event. I want to plug our, uh, our all access event tomorrow, and now I'm done employing, and now we're going to rip the stocks. And I had a couple out of the chat Spencer. We're going to do Baba. Does it mean we have crypto? Yes, I believe so. Caleb, uh, okay. Uh, we're stocks.
Let's go first up on the list. Guys. If you have symbols, drop them in the chat we're diving straight in. We're going to try to five stocks, 15 minutes, three minutes, a piece, a naked brand cigarette, N a K D November alpha, kilo Delta. Uh, here is the look at the daily charts. Daily looks decent. We zoom it in to the minute charts.
First time of the day. We're starting to see a, a little bit of trouble over these past few minutes. Um, Spencer, any takes there? I have an opinion. Yeah. I have an embarrassing confession to make until about a minute ago because I've heard of naked brands before. And I've heard of like, I've obviously heard of the stock because it's a, it's a high flyer.
But until a minute ago, I honestly thought that this was the company that made naked juice and that's wrong. That is absolutely incorrect. That is wrong. But I. I thought this was naked. Thank you. Nope. Now that'd be a negative this entire time. This thing got to, you know, this thing went to three 50 or three 40 back in January go to their real websites.
Spencer, what? Naked brains.com. I don't know. Try it. Yeah, sure. Um, yeah, this is it. Okay. So for, for, for nine months I felt naked was like, it was the juice company that they make those really strong, fruity vegetable drinks. Now that'd be a negative. That was wrong. Okay. That shows you what I know anyway. Um, they can brands, this is their actual website, so let's go to the chart.
All right. So, so, so, so back to the chart, Spencer here, let me take it back over. Okay. All right. D here here's the daily candles. Okay. We're we're, we're, we're above this, this previous high that we had in there. Okay. We broke above that today. We, we got directed below. Ah, we got rejected. Below that on Friday, next previous high we're looking out for is all the way off at a bottle.
My I am long and strong naked right now. My opinion is that if, if we can buck this downturn that we've seen between when the show started and right now, uh, we're, we're in a decent position to keep running. This is definitely one of those docs that gets Mimi. It gets Rippy look at this, right. We saw that hop earlier this year from like 20 cents up to $3 and 50 cents.
Does it get there? I would, I would be skeptical, but if the momentum continues today, I think a dollar is absolutely insight, uh, from a pure technical basis. Yeah. A but a dollar is also like so pure technical energy to baby naked brand says energy power. You were just on the. I I'm, I'm just saying like a dollar is like, so psychologically significant that if like, okay.
I would just say if I wanted to, I don't even know if you can short the stock, but if you want shorter and you could, you, you wouldn't wait till a dollar, you would go, like, I I'm sure there's a lot of people at like 99 cents is all I'm saying. Sure. Yeah. Yeah. 95. I'll take it. Okay. 95, whatever. So, and strong.
I'm letting it rip today again, but between when this show started in now, what was the first sign of trouble that we've run into today? Right? These are the minute candles, uh, and we had a couple of decent size grad bars, but, but we'll see we're at 80 cents right now where we got to, uh, 80, almost 83 cents.
This, uh, that was the high of the day. So. There's one, five stocks, 15 minutes. Do you want me to call it or you want to pick next? All right. Next would be Sackler day. Ticker BBI, G Vinco ventures. Spencer. You talk to the CEO or chairman of the company. I don't remember which so the view. Okay. Remind us what the company does.
A Tik TOK. Uh, can I, it, it is take of India. Yeah, India and, and other geographies. Yeah. Right now we're looking at daily candles, obviously a ton of volatility over the past couple of weeks today, the stock is back in action. Up 16%, no news out on it. Um, I I'm, I'm curious. Where is everybody at with, with BB?
I G if you like the stock right now, drop the one in the chat. If not drop the. And, and even for, for let's, let's just play imagination. Okay. It's Monday, we got to wake up our fingers a little bit. If you're not taking a position one way or another one in the chat, if you would buy it here, two of you would sell it here.
I'm curious where everybody is at to having an opinion, too, for Spencer, I would sell it here. Um, I'm also a seller here, uh, and I'll back it up trend is your friend where we're in a downward trend for the past couple of weeks, uh, that the, the candle for today just moved rad, which means the stock is trading where below where it opened.
It's still obviously above where it closed on Friday, but we're now back below where it opened. Uh, we, we have the downward momentum. Uh, we have the red candle today. We have no news, uh, that, that came out to justify the pop that took place today. And so, um, I'm also going with the. Yeah, I would be against it.
If I had to pick one way or another important number on this is $8, right. That was the high that we got to add. So, uh, five 30 this morning, we are $8. So we're w we're we're, we're further off than it looks. If you only look, if you're ignoring the pre-market session, you're, you're missing the higher, the day $8 there.
So I would sell BBG here and I would, yeah, this is, this is not my style. This is your style. It's not my style. I love these types of styles. We're doing Rippy stocks today. All right. We did too. But I like BBG. I don't. All right. It could be wrong on him, but, but that's the way that I'm playing it today. And chat is pretty divided on this one.
We have just about as many ones as we do twos again, one was people like. Two was people don't. What about Celsius? All right. Let's, let's look at Celsius next. And then we're going to get to Baba in a second here, uh, Celsius. Uh, I'm also long and strong Celsius. If you don't know this one, it's like an alternative energy drink maker.
It's like, uh, uh, basically slightly healthier energy drinks, but I'm still, I'm sure. Still not great for you. Uh, you know, uh, all, all the fundamentals continue to be strong except for the valuation ratios on this one. And what I mean by that is that sales are still flying off the shelves. The company sells inventory problems because demand has been so.
The stock is very, very expensive. It's trading the teens of, of, of, of price, price to sales versus maybe like a four and a half times ratio on average for the S and P 500. Uh, that's sad. The sales growth, I think will keep the momentum alive. So I have been long and strong, uh, Celsius from the seventies.
Wow. We're at, I know it's a good grade. So do you have a plan here or are you just riding the wave? I'm riding the wave baby. If momentum cracks that, then we'll hop on. Um, what does that mean? If momentum cracks, if we get so, so today we're off 5%. That's a painful day. It's the biggest loser in my portfolio was a position.
It was, it was, it was a big position that one of the largest positions that I put on it grew to be larger. We're off 5% today. The, the portfolio is, is definitely bleeding from that one still green today. Thank goodness. But this is, this is the biggest, the biggest hit to the portfolio of the day. Uh, if we get another ride candle like this tomorrow, uh that's when I'll start rotating out of it.
Yep. So all it'll take is, is like another, another 5% day. Yeah, yeah, yeah. We have a 1% day. Okay. Maybe the tide is turning, but if it's another day of, of rad and we're down off another 5% Obama out of it. Wow. Okay. Short pay, uh, short trigger finger. I like it. Cause, cause you've got. Yeah, exactly right. It's been several weeks.
We wrote it from 70 to 95 right now. Great freaking trait. Thank you, sir. Yeah. So now he's going to wait, you know, right in 94. So let's say if Luke wakes up tomorrow and saw ceases at 90, he's done. And, and, and here's what I'll say too. Obviously we can't predict too far into the future, but this is a stock that I will absolutely look at to trade into earnings again.
So it's the next earnings date is scheduled for 11, 11. Make-A-Wish Spencer. Whoa. And here's the, but it's one that, again, I'm not, I'm not saying that I would, would hit it long back into earnings, but it's one that I will absolutely look out long back into earnings. Because again, that the story is, is, is the fundamental one.
The stock has the momentum right now, um, which I check out the sales growth on this. And Spencer's, this is quarterly revenue. Uh, over the past year, we went from $30 million of sales to $65 million. What is the market cap here? I said that all the fundamentals are great, except for the ratios. Okay. For a company that made 60 million mill million with an M quarter of quarter.
All right. Here's my question. Is are they going to, going to come out and blame a supply chain of woes? Yeah, but they already have. Oh, they did. Okay. Revenue will still be good. They'll still blame supply chain and they'll they'll they'll beat and raise again. That's all I do. They're just beaten. Or he's beaten, raised, beaten race.
Fine quarter after quarter after quarter. Oh man. I know. Look I, who am I to poopoo this you've written the wave. Great trade. The new Navy. I just ride wave valuation means nothing. When you're up in your position, when you're down, it means everything. But when you're up, it means nothing. So it's a great track.
Good. Great job, man. Good job. Alright. Five stocks, 15 minutes next up on the shot pocket. Yeah, this is Alibaba's thing is, is, um, I can understand why you would look at this. Why anyone would look at this and say, oh, how could I not take a flyer? Right. It got to 1 44 this morning. I can understand the temptation for a stock that was basically $300 a year ago.
It was 300 pockets. It's coming to zoom. Yeah, Spencer. So, so now we're looking at a five-year chart with, I believe monthly candles. Yes. These are monthly candles. I now brutal. It's brutal. It's brutal. Um, if you want to take a flyer, I guess I would say if you do whatever you want, but waiting the flyer on this one is with long dated calls.
In my opinion, we, we, we, we looked at them briefly last week. I didn't take any action on it, but, but, but basically I think it was though one 70 calls that were about a year and three months out, 15 months out or something like 13 bucks. So, so it's definitely on my, keep an eye on it list. I think if you want to take a flyer, it's a pretty capital efficient way to do it.
That's PR yes. That's probably the most efficient way to do it is, is, is leaps. Um, cause you know, you have it, you have it defined a risk and, and it's efficient use of capital and you're you, and you're not married to the next few months or because this thing could, oh, who knows where it's going to stop, but.
I don't know, like part of me wants to, and part of me doesn't, I'm hands off for now, but it, gosh, does it walk? Does it look like a snack as Neil would say, right. I 1 48 here do it Spence. I I'm not going to do it, but there was a part of me that absolutely wants to do it, wants to buy this stock or, or I'll buy some long data calls or whatever, thinking about it in the chat.
Uh, he sold Baba puts for one 20 expiring this Friday. Wow. Yeah, I think it's a decent trade. It can't be a highly lucrative trade. So basically as long as Bob was at one 20 or above by Friday. So it's 1 21. No, not one 20. Cause it's it's whatever he, he pocketed from, from the sale. Right. So let's say it's a dollar.
It's not going to be much. No. All right. You're right. You're right. Um, all right. If anybody else has any action on Baba, put your trade in the chat long, short. I want to see where that's at. Yeah, it does. Look, I look, you guys know, I own all these Chinese internet stocks for, for years. And then I sold via the one ETF and I sold that and I'm out and Spencer five stocks, 15 minutes more on the list.
One more. And then we're going to have to bring on our guest, our first guest, the one on Europe on your list. G G all right. We have a new spec deal guys. News one year chart, daily candles. This was a pre announced back and has now announced a deal. Uh, I know that we're coming off of SPACs attack. Uh, but, but this one, we, we have a little bit of a.
Experienced with a company called Pollstar, which is Volvo's, uh, electric vehicles. Company has been funding. You, you test drove this car, did you not? I drove the shit out of this car. I would say Spencer. Th that's the technical term. That's the technical term. Yes, we, we got one of these vehicles at Benzinga, uh, again for fully electric car it's it's the company that, that Volvo has been funding, uh, and it was a pretty awesome ride.
Uh, you know, the styling, I didn't think was like very impressive or interesting. Like we see out of a lot of these new Evie companies, uh, but the drive was incredibly smooth. The car was incredibly fast and the interior was, was great, uh, amazingly comfortable. Um, so, so I was a, a big fan of the drive experience on the book.
Okay. I, I mean, I w I wouldn't know, I wasn't invited, but it looks amazing. I will say that it looks nice. And in this, the thing was fast, Spencer, I didn't even have the fast version. All these electric cars are so fast. Th the only thing, like, you know, what's wild here is like, okay, in Eve you spec the old th that's.
So in an EVs back in September, that is so 20, 20. That's like, you know what I mean? Not so lucid of them, these guys are like a year late, aren't they? No, yes. So, so here, here's my, here's my take on the trade. Uh, if I had to pick one way or another, uh, and, and, and I may get into this one later today, I would pick it long.
Uh, again, I think it's, it's one of those names that the vehicle is, is interesting to look at. It's headline. Um, they, they are starting to get out onto the roads, at least in a test capacity. Um, so it's a little bit further along than lucid as I believe. Uh, but if I had to pick this one for a swing trade one way or another, I would definitely think along.
Wow. All right. I was surprised to see this today. I didn't, I thought we were done with the EVs facts, but I, yeah, I thought we were done with the, I guess we're not. All right. Look, we're running a little bit late here. Uh, we got to bring on our first gas. All right. All right. Let's do a Spence. All right, Dr.
Adam Caplin, who has forgotten more about science than you and I were even know he's a PhD. He's also the chief scientific officer of my M D pharmaceuticals. Here we go. Dr. Caplin. Good morning, sir. Oh, no, you're on mute. Check that mute button on the bottom there. Thank you. Technical things that are difficult.
Always the technical things that are tricky and. I'm doing well. And how are you, Spencer? It's a beautiful day. We finally have our fall a days here in Baltimore, so we're enjoying ourselves. Nice, nice. I have a soft spot for Baltimore. I went to the university of Maryland and so I have a soft spot for Baltimore and, and, and that state, uh, Adam, let's talk about my MD for a second.
Thank you to ever put the, uh, the ticker up on the screen there. Uh, that wasn't me, uh, for those who don't know, tell us what, uh, my MBA, what you're working on. Well, we're working on two main, um, uh, drugs under development. One is my MD one and the other is superior CBD. My MD one is looking to be, um, a game changer in the area of treating auto-immune diseases and delaying aging and superior CBD is as the name implies a super new form of CBD.
Explain that a super new form of, yeah. So essentially it's not a huge change to the molecule. Um, it takes one of the six member rings and turns it into a five member ring. Um, more details than you would possibly want to know, but essentially the Tran, uh, the, the outcome of that is that not only, um, so first of all, you have to understand there's two binding sites that we all have within our bodies and our brains and the immune system for any cannabinoid, meaning THC, any marijuana based drug, um, one is CBD one, the other is CBD.
Sydney one is what gives you the intoxication? The high from THC and marijuana CBD too, though, is a really unique receptor. That is the brake of the immune system and has very potent anti-inflammatory effects and the ability to help preserve neurons, um, and preserve, uh, you know, the brain other under attack.
So what's really unique is we first found that superior CBD bound four times more tightly to the CB two receptor, but binding isn't the isn't the key. The key is once then, what does it do? And it turns out that superior CBD when it's bound to that CB two receptor, the one that's on all the immune cells and in the brain under, uh, under attack, either epilepsy in the light.
Is, um, 8,000 times more potent at activating the CB two receptor. So that's a huge difference. It really is a very potent drug at activating the OD the break for the immune system and preserving neuron, neuronal function of the brain. What exactly is going on here? You have, you have, uh, studies, uh, you have two drugs in the pipeline.
You have studies going. What is the status of those? Where are you in the regulatory? Yeah. So that's a great question. With superior CBD, we are doing the preclinical studies. It's the newer kid on the block for us. And, um, we are currently undergoing all of the, uh, regulatory toxicology studies and safety studies were about a year from being able to get that into humans.
Um, my one has already completed its phase one studies. And this year we plan to start two studies, one looking at aging and the other, looking at COVID-19 to treat inflammation and, and to slow aging down. All right. So we're still early days in this. Process for the superior CBD, where early days for my MD, when we're getting into phase two sorority, looking at treatments for aging, and COVID-19 in humans this year, we're going to start to two of those studies.
So we're much further along it's, it's, uh, a molecule that we've been working on a much longer. How long have you been working on it? Um, it has been roughly four years. I should tell you, I joined the company a year ago. So, um, you know, I most familiar with the stuff that's happened since then, but, but it has been, uh, working on, we've been working on it for four years.
So we have the safety, uh, the toxicology studies and all of those. Uh, and do you have, I guess you're, you're getting into phase two right now. Uh, do you have an idea of when, of when that could start even, even end the, the. Yeah. So there's two trials. One is that COVID-19, um, you know, it's obviously still going on, which really dramatic about COVID 19 is that it's the inflammation that causes all the trouble.
And so my NB one is, has both good effects on blocking inflammation and bringing it down and slowing aging. I'm happy to talk about a very exciting study that's under review right now, um, out of a major academic institution, but, um, so the first thing, the COVID 19, it turns out that that inflammation has effects on the brain, including brain fog and depression, post COVID.
These are very common up to 50% of people will have, um, a post COVID depression due to the inflammation and this brain fog that often goes along with it. So we are studying the ability of my to treat that, and that will be a second. Uh, treatment trial. So because it's only six weeks, we should be able to get everybody enrolled, um, this year and have the results in the first quarter of next year.
The second study is on aging and that study will be a six month trial. So we started this year. Um, it's going to be probably a fourth quarter of next year that we'll have the results. Alright, so I have, uh, two, two trial results, one in the first quarter, one probably around a year from now. Yeah, that's that's I think that's a reasonable assessment.
Can I tell you about the, the aging, uh, the result out of this, a major academic institution what's really remarkable is that currently the best treatment that has been seen in animals to extend the lifespan of animals in terms of a drug is rapid myosin. So this study using my MD was comparing my MB to rapid myosin and rapid myosin plus Metformin, but that.
Complicate things and what happened, but you have to understand finding a drug that can actually delay aging is so critical. So this study took mice that were the human equivalent of 60 years old and treated them until they were the human equivalent of 90. And essentially being on meant that you were four times, 400% less likely to die.
If you're on the, my MD than if you were on the rapid myosin. And that's a huge impact, highly statistically significant. And we think we're working towards an understanding of how this actually works. The critical thing, Spencer though, is it didn't just extend the lifespan. It, these mice retain their. And their cognition.
So it's not just a drug that could, if it works in humans, like it works in mice, uh, extend the human lifespan. It could slow aging. So it's not like we're all just going to get old and demented, we're all going to lead longer, more productive lives. If it doesn't humans would it doesn't matter. All right.
Well, we'll know more regardless. Uh, next year, Adam Kaplan is the chief scientific officer of my MD to grim YMD, we'll know more from the one trial and in Q1 and then the, the, the longer trial, uh, in, in, in Q4, hopefully next year, Adam, thanks for coming today. Thank you so much, but if you're always a pleasure to work with you and right.
I see a bee producer. AB is he here? I just saw him. I just saw him producer. AVRC you lurking. I see you lurking. Uh, while he's getting his stuff together, let's just do a real quick. Crypto update because, uh, I oh, there is. I heard my name. Yeah. Hey, how's it going? Tell the people why you leave today. Um, so I was just at a press conference at, uh, the Detroit golf club for the rocket mortgage classic.
Uh, they were announcing that rocket mortgage is extending their sponsorship of the tournament, um, through 2027. So some exciting news, just have one question. Will Phil Mickelson be at the next one? I don't think so. Based on last time he, uh, some Detroit writer did not make him happy. Yes. Yes. Anyway, wait, I just want to do a quick, quick crypto update then we'll go to our next, get our next guys.
Cause that same here real fast. AB why did you bother different crypt? They want a Friday, cause I did not. I kind of a. Uh, I just didn't. I know, but, uh, Spencer, so I'm in a couple fantasy football leagues where we're talking about, well, really just one. We were talking about like putting our pool for the league into crypto and we were texting this weekend, like, oh, now would be a good time to throw it, you know, in a theater.
We want, we want to throw it in something that really has a chance to like double in the next six months.
Okay. Hey, however you figure that out. You let me know. Okay. Got it. Yeah. I'll let you know how it goes. Uh, whether it's Towanna, uh, eith I dunno, BTC. Those are the three that I on Cardona. I dunno. Um, but here let's you go to a charter for a second and then we'll, and then we'll go to our guests. Yeah. So, so we had that sell off on Friday and it happened, like, you can see there that we actually closed, you know, about halfway between, uh, the high and low of the day in Bitcoin.
And so, uh, we kind of came back so fast. It, I kind of feel like I missed my chance, so I didn't, I didn't do anything basically. In summary, I did nothing on Friday. I thought about it. I talked about it and I did nothing. It's the same thing, right? Charts are identical thought about it. Did nothing. I want to know if anyone bought more.
I should have, I, I, I always regret not buying more. Every time I regret not, I think on, on some different brokerages now you can set recurring buys. So like, I don't think it would be dumb to set. I should've just dollar cost average. I don't know how, I don't know how to set it up though. Maybe I, I, what brokerage are you using?
Yeah, I'm using Coinbase. Is that, is that bad? I don't know. I mean, I'm sure on Coinbase, I know Robin hood, they just like enabled recurrent investments into crypto. So I'd imagine Coinbase. So you can too, um, since obviously Coinbase is more crypto focused than the only reason I use Coinbase is cause I literally just like did eeny meeny, miny, Moe.
I was a guy one like, yeah. There's no special reason why, why I use it. It was, it was a spontaneous thing. I didn't think about it. I didn't do any research. I didn't think about it at all. I just did it. Um, anyway, speaking of crypto and buying it, you can get $50 in Bitcoin for free. All you gotta do is download the Voyager act.
Fund your account with a hundred dollars, make your first trade and use the offer code zing that Z I N G it's up on the screen that will get you $50 in Bitcoin for free. The crypto updates that we do are brought to you by Voyager. I should, maybe I should just, I should probably switch off Coinbase. I, I have no allegiance to them at all.
Even if you go to Voyager. Yeah. I don't know. I don't know because I swear, I don't know how to use that app at all. Anyway. Uh, okay.AB it's 1247 and we didn't get to any of your stocks that I don't know what you, what you have on your, yeah, I've got a couple of things, Spencer. So first of all, um, you know, if you notice the title of this video stock market crash or new all time, and you're wondering, uh, you know, what's sad about, so over the weekend, um, the real Kiyosaki, I hope I'm saying that, right?
I saw this tweet tweet on Twitter. He made a big waves in the fin twit community. This is the author of rich dad, poor dad, which is a very popular book among investors. Um, full disclosure. I have not read it. Let me know in the chat, if you think like, oh, B you must read this book. Or if you're like, oh, you've, you've made it this far without reading it.
You don't need to. Um, you know, so anyway, he, he tweeted giant stock market crash. Come in October. Why treasury and fed short of T-bills gold, silver Bitcoin may crash to cash best for picking up bargains after crash, not selling gold, silver Bitcoin yet have lots of cash for life after stock market crash stocks, dangerous.
Careful. So this caught a lot of headwind among the investors. Um, you know, uh, this guy Kiyosaki, he's known for kind of making some hot takes on Twitter regarding Bitcoin. Yeah. I never met him. I don't know him. I've also never read his book, but I will say this. He has made these calls before. This is not the first time that he has come out and well, I'm glad you mentioned that Spencer.
Cause I was just going to bring up this in the replies and someone essentially like super imposed some of his tweets over the S and P 500. So dating back to 2011, um, you know, he's been calling for a crash like periodically, uh, I'm an actor and actually here, let me try to zoom in a little bit. So you guys can see Spencer.
I don't know if you can make this full screen. So here, um, this one in 2018, he's he retweeted an article, I guess essentially saying that a biggest crash has come in and to his credit, there was a strong dip, uh, kind of like directly after that, but nothing really of a crash. And the only time he was ever somewhat vindicated was here in the COVID crash, which of course, uh, you know, an obvious factors playing into it.
Other than just, he said the crash is beginning on April 17th. It was already over by. Oh, no. Yeah. He's yeah. Crash only beginning, April 17th and the, and the markets from then, you know, went way higher than the previous levels before the COVID. So, you know, to say he's been wrong numerous times and calling this out would be kind of an understatement.
Someone else on Twitter, you know, said, if you listen to him, your returns would be 0% since 2012, because, uh, I guess 2012 was the first time he recommended kind of going all cash. Um, so I don't know. So it's, I mean, it's one of those things to me, that guys like this, that, that keep calling for a crash eventually they'll say, Hey look, I was right.
But it's like, yeah, but you were wrong for 10 plus years and you missed out on all these gains, you know, from the spy. Yeah. Christian gala Gallagher, and the Chad saying he will be right eventually. I mean, yeah. If I keep saying, Hey, the, you know, the market's going to be down every day. Eventually I'll be right.
I, if you call for the world to end one day, the world's going to end. You're going to be right. It's just a question of, are you alive? Yeah, right. Um, so, so I, you, so the title of this video, again, I made it stock market or new all time, high stock market crash, or new all time highs. Spencer, we've talked about this before.
You and I are both on the side that we will see new all-time highs before the end of the year. That's not saying we're, you know, Betty don't, you know, whatever. We're just, if we had to pick, will there be new all time highs or will there not be we're on the side that we think there will be? So, yeah, I have a bet on with joy and the bet is referring to the S and P 500 specifically, which I actually don't know how great I feel about that because the more I look at the spa or the S and P 500, the more I realize, not that I haven't known this, we've all known this obviously, but the spy really is just, it's just six stocks, right?
It's it's it's fat man. Right? F a T M a N. Right? It's Facebook, apple, Tesla, Microsoft. Alphabet, Amazon Netflix, right? Those right. I got there, right. Fat man. Yeah. Fat, M a N uh, seven, seven stocks. And whatever those seven stocks do is going to be whatever the S and P does. Uh, w w let's just do a quick, let's just do a quick, um, let me go here we go.
Want me go to ETF, db.com and we can, excuse me, let's do some quick math in our heads. All right. No, not in our heads. Yeah. In our heads. Okay. Uh, let's let's add up these, these holdings. So apple is six plus six. We'll call it 12. Uh, we'll call that 16. Uh, we'll call that 18. We'll call that 20, uh, oh, wait.
It's actually, um, Yeah, it's alphabet for cause there's two share classes, but, uh, uh, so call it 22, call Tesla. We'll just call it 20. You want to call it 25? Ian we'll call it twenty-five even actually the end in fact, man could be Nvidia. We'll call it 20 or so. So 1, 2, 3, 4, 5, 6 stocks are 25% of the S and P give or take.
Um, it's not exactly, obviously. Um, and so it's, whatever those six are going to do is whatever the spine is going to do, basically. Right? So a day like today, where like you could say the market is up Mo there was way more green than there is right today. And yet the spies on the red, because those six stocks are not.
But if you look at the IWM. I have a great day. Wow. I'm looking at Tesla right now up about two and a half percent, almost at $800. I feel like Tesla has quietly, um, you know, gotten back up to $800, maybe a little bit absent with some of the attention that Tesla has gotten in its previous runs, maybe, cause it's just been kind of a steady climb to 800 over the past, uh, you know, four months or so, as opposed to it being up 10% every day or whatever.
But, uh, I mean the chart looks insanely good right now. Congratulations. Hertz comes and says that was as best day all year. That's great. Um, so anyway, to bring it full circle, I do have a bet on that thing that says, we'll get the essence, a new all-time high in the S and P by the end of the year. Um, but it's really what it comes down to is whatever those six docs do is what it's, what the SOP is going to do.
So I, I'm going to try and wean myself off of the S and P um, it's hard though, to just use it as your gauge, but. I'm still balling. You're saying you don't think it's a effective gauge because it's so heavily weighted among those. Yeah. I mean, we talked about, we've been talking about this for months. I'm pre-market prep, but it's hard to change to change your behavior.
And I did recently, not recently, like a year ago, I think I changed the weightings in my, this is like super, like, I don't know, not narrative, you're not wonky, but this is just like, this is super boring, but I changed the weightings in my 401k to be 75. I have two funds, a small cap and a large cap, and I made it to be 75% small cap, 25% of large cap.
Wow. Yeah. Um, what was the thought process going into that? Originally? It was flipped and then I, I realized, no, I want to play with the other way. Small caps is a historically outperformed and well large caps. It's this it's really not, it's not even large cap. Six mega caps. And I was like, I don't want these six docs.
So essentially, I mean, obviously, you know, you said small caps, like historically tend to over-perform, but I think over the last, like 10, 15 years though, you know, the apples, the Google Facebook have just had ridiculous returns compared to the small cap. So you're saying essentially you're betting on that.
There'll be a, kind of like a reversion to the means and the small caps got to catch up with these big guys eventually. Yeah. I mean, there, there is data. Hold on a sec. I'm trying to find the page where I, uh, where I, I favorite thing, I kind of agree because it's like, look from 2000 to now 2021 for the past 21 years, the best investments have been, you know, Amazon, apple, Google.
And I think it's like time now that we start looking. Forward to the next, um, you know, what will be the next, the best investments of the next 20 years? Maybe it, maybe it is still apple, Google, whatever, but I think we might, you know, get some new, um, see, I just don't know. What's what are the most innovative companies out there right now, um, that are going to be more that are going to be able to grow at the pace that apple, Google?
I don't know. So when I say historically small caps outperform, I'm not referring to the last decade. The last decade, large, you guys know this large caps, dominate, dominate, dominate, dominate annual, um, gain of call we'll we'll call it temporary. We just round up, but call it 10%, right? Just 9.8% annualized gains, huge small caps around 8.9%.
Uh, but if you go back like 20, 30, 40, 50 years, small caps have the edge, if you go back further. So I, I don't know the answer to your question AB um, But maybe, maybe it's the group of stocks that's been like that we're like rallying, like crazy. And I've been beaten down this year. Saw someone mentioned DocuSign.
DocuSign is actually held up, rotate that stock's just so expensive. I feel like, I don't know. That's the problem is he, these stocks like, like you, you might love a zoom or DocuSign or a, I don't know, a Roku or a square, but they're just, I think let's think about it this way. So the companies, the mega caps that have grown over the past 20 years so much, you know, whether we're talking apple, Microsoft, Google, um, they're they were kind of in emerging markets in a way.
So you think about it like apple, like smartphones. When smartphones became popularized, apple was in a position to put out the iPhone and become the most popular smartphone smartphone. So I think if we look at like, what markets do we expect to continue to grow? So, you know, we've seen it with EVs where like a lot of these companies, like you said, just got super expensive and then now are, are getting beaten down.
I think there will be kind of winners and losers out of those. Like, I don't think every single Evie stock that ran back and who's going to pick the winner. Not me, not me. Probably Warren, probably, maybe no. Warren, you think Warren Buffett's in a bind and Eve stocker you're out of your mind? Not now. Well, Spencer.
He, one of his biggest holdings is in a BYD, which is an Evie company. Second of all, I think once he is able to identify like the companies that make money, these Evie companies don't make money. Well, like I said, he's a big investor in this BYD Evie company, so he's got to believe in it somewhat. Um, yeah.
Thank you, Chris. Backing me up in the chat. Uh, I think he'll, he'll recognize be able to recognize which one of these companies will be able to make a bunch of money. Um, other emerging markets that I could see coming in the next 20 years, I think there's a lot of, um, things in the medical field that will be big, whether that's tele-health, whether that's, uh, and I'm not just talking like biotech companies that make different drugs.
I I'm saying like companies that will kind of like revolutionize health. Uh, so I've already made these calls in my portfolio. I've already made these calls. Okay. Here are your big ones. This is my portfolio. Okay. Let me make the names bigger so you all can see, okay. I've already made these sector. I like making sector wide calls.
Okay. I've got cannabis. I've got cyberspace. I've got 5g. I've got e-sports. I have a very, very, very small piece of space. I literally have got like, probably like 10 chairs of space of, of UFO. Right. Very small. Okay. I've got a biotech. I've got this, uh, the, um, uh, SRV, R it's it's a, it's a data center REIT.
It's basically just like, it's a read that owns data centers and server centers. Okay. Love it. Everyone needs data. Now, whether you're in the sports gambling industry, whether you're in healthcare, everyone needs, everyone needs. Yep. I've got blog. I've got the blockchain ETF, a little bit of that. I've got clean energy PBD.
I've got small cap industrials and the, and these are the calls that I'm making. And for a lot of the year, it's been pretty brutal to be in e-sports. For example, it's been horrible, but I don't care about this year in e-sports. So I've made my calls, cannabis, cybersecurity, e-sports 5g biotech server. Ah, small cap industrials and clean energy.
That's what I've got a Christian there's two BYD is there's Boyd gaming. Um, which is what I think you're referring to. There's also someone through the ticker in the chat it's on the OTC, since it's based out of China, it's like BYU DDF, I believe. Um, it is a Chinese Evy battery maker, or maybe they make cars too.
I don't know either way Burke share, uh, and Warren buffet holds a significant stake in there. So, um, might be wanting to check out, but Spencer, we are wrapping out of time. I'm going to see if Neil is ready. Um, oh yeah, shout out and Verso win a year of Benzinga pro entered one a year. Benzinga pro if you sign up for our healthcare conference, that is starting on Wednesday.
Um, if you go to BZ, small cap.com, you can sign up for free and, uh, yeah. Enter to win a free year. Benzinga pro yeah. I have a last thing to plug again. Just as a reminder, check out the Benzinga Moomoo trading competition. AB probably has no idea what this is, but that's okay. He's not paying attention. Uh, so click on the link in the description.
First place gets 24 shares of Nvidia for a free second place gets 12. Yeah, it's, that's a lot of money. Five grand, man. Am I allowed to participate yet? It's yes. Click on the link in the description. I already have some shares of Nvidia, but for opening an account or Moomoo funding with the $500 and you are eligible to, to participate in the Moomoo and Benzinga us paper trading competition.
Uh, the last day to enter is October 15th and it ends on the 29th. So the link is in description. It's also in the chat and don't say, didn't warn you because I do. I warned you. There we go. All right. That's a wrap for power hour today. Let's get Neil going on, get technical, everyone smash that like button and, uh, we'll see.
Y'all later. It's the green today. Everyone. It's a green, it's a green day.
Support this podcast at — https://redcircle.com/zingernation-power-hour/exclusive-content
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
More shows like Benzinga LIVE
View all
PreMarket Prep
82 Listeners
Benzinga Cannabis Hour
8 Listeners
The RazReport
23 Listeners
Ring The Bell At The Close
0 Listeners
Moon Or Bust
4 Listeners
Cannabis Daily
13 Listeners
The Roadmap
1 Listeners
The Long Run Show
3 Listeners
Crypto Breakdown
0 Listeners
Benzinga Trading School
1 Listeners
Inside Wall Street
0 Listeners
Benzinga Daily Stocks To Watch
9 Listeners
The Benzinga Real Estate Podcast
0 Listeners
Stock Market Movers
0 Listeners
The Benzinga Interviews
0 Listeners
Crypto Open Mic
0 Listeners